Real World Posaconazole Pharmacokinetic Data in Paediatric Stem Cell Transplant Recipients
<b>Background:</b> Invasive fungal disease is a significant cause of morbidity and mortality in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients. Posaconazole, a broad-spectrum triazole, is widely used as prophylaxis. <b>Methods:</b> We conducted a monocent...
Saved in:
| Main Authors: | Csaba Kassa, Katalin Csordás, Lídia Hau, Orsolya Horváth, Krisztián Kállay, Gabriella Kertész, Márton Kiss, János Sinkó, Ágnes Wolfort, Gergely Kriván |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/4/467 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review
by: Ruochen Qu, et al.
Published: (2024-12-01) -
Relapse of COVID-19-associated mucormycosis in patients receiving posaconazole as maintenance treatment
by: Mohammadreza Salehi, et al.
Published: (2024-09-01) -
Intravenous posaconazole: key features of clinical pharmacology and practical applications
by: A. V. Veselov, et al.
Published: (2022-04-01) -
A Rare Complication in a Patient with Acute Promyelocytic Leukemia; ATRA and Posaconazole Associated Hypercalcemia
by: Yeşim Yiğit, et al.
Published: (2024-09-01) -
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
by: Eliane Vanhoffelen, et al.
Published: (2025-04-01)